Clinical Trials Browser

Phase 1/2 × BKT140 × Plasma cell × Clear all

NCT01010880 2011-06-10

Safety Study of a Chemokine Receptor (CXCR4) Antagonist in Multiple Myeloma Patients

Phase 1/2 Completed

Multiple Myeloma